Navigation Links
Caliper Life Sciences Reports First Quarter 2008 Results
Date:5/8/2008

ngservice.com/prereg/key.process?key=PRYBLGWL9.

A live webcast of the call can be accessed at http://www.fulldisclosure.com or on the Caliper website at http://www.caliperLS.com in the Events section of the Investor Relations page. A webcast replay of the call will remain available until Caliper's earnings call for the second quarter of 2008.

Telephone replays of the conference call will be available approximately two hours after the completion of the call on May 8 until May 15, 2008. To access a telephone playback of the proceedings, dial 888.286.8010 and use the participant passcode 20551909. International callers can access the playback by dialing 617.801.6888 and using the same participant passcode.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit http://www.caliperLS.com.

The statements in this press release regarding future events, including statements regarding Caliper's expected financial results for the second quarter ending June 30, 2008 and for fiscal year 2008, Caliper's beliefs regarding the future growth rate performance of its microfluidic and imaging products, the ability of our CDAS business to make up for certain revenue shortfalls over the remainder of 2008, a
'/>"/>

SOURCE Caliper Life Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results
2. Caliper Life Sciences Ships 500th IVIS Imaging System
3. Derma Sciences Announces Date of Its First Quarter 2008 Earnings Release and Conference Call on May 15, 2008
4. Applied Precision Announces Sale of Life Sciences Business Unit to Senior Management and Telegraph Hill Partners
5. Argonnes Crabtree Elected to National Academy of Sciences
6. 2 NYU faculty elected to National Academy of Sciences
7. Derma Sciences Receives Third FDA Clearance for MEDIHONEY(TM) Wound & Burn Dressings
8. Arkion(R) Life Sciences Receives Crisis Exemption to US EPA Section 18 Approval in Mississippi and Tennessee to Market Avitec Corn Seed Treatment
9. Microsoft Health & Life Sciences Developer and Solutions Conference to Feature the Latest Microsoft-Based Software Solutions
10. Life Sciences Fund grants awards to launch health research
11. Life Sciences Discovery Fund Awards $2.2 Million to Support New Solid-Tumor Research Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...USNewswire/ -- The American Academy of Actuarie ... legislation released this week to contain stronge... coverage mandate. The actuaries said that an effe...e selection stemming from more restrictive issue a... individual mandate language should be strengthene...
(Date:11/20/2009)...ssmen in Competitive Re-election Battles Could Be ... Washington, DC (Vocus) November 20...election next year in races deemed to be competiti...ret voting for House Speaker Nancy Pelosi’s ...ternational/ O’Leary Report poll. (The Pol...
(Date:11/20/2009)...FirstCall/ -- Centene Corporation (NYSE: CNC )...of America Merrill Lynch 2009 Credit Conference, t...Hotel Times Square in New York City. ,, Centene... Eastern Time. Investors and other interested part...presentation at: http://www.veracast.com/webcasts...
(Date:11/20/2009)...wswire/ -- The following is a statement by Charles...re Association: ,, "The Nevada Health Care Asso... Leader Harry Reid for his leadership in taking ou...ng every Nevada seniors, ongoing access to quality...d viability of our state,s vital frontline workfor...
(Date:11/20/2009)...used for embalming in the funeral industry were as...oid leukemia, according to a new study published o...Cancer Institute . , Previous studies have shown...ncies and brain cancer in anatomists, pathologists...ve worked with formaldehyde. , For this study,...
Breaking Medicine News(10 mins):Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2
...meday yield therapies to restore sight, experts su...s) -- A gene that plays a major role in two forms ...nternational team of researchers. , The discovery ...nal metabolic disease pathway that might be crucia...
...ect care patients might get, experts warn , ...ercent of those training to be dietitians have pos...bese, and the rest are moderately biased against t...ive attitudes toward obese patients that may have ...
... Phoenix Health Systems, a national provider of he...lting and business process solutions, announced to...o offer hospitals and other healthcare organizatio...goes beyond regulated compliance requirements to m...
...rope and Asia to Realize New Executive Leadership ...9: Tokyo Stock Exchange), a leading medical diagn...rmation systems developer, today announced executi...n to Sysmex Corporate after a six-year tenure in t...
...new study headed by Dr. Tom Feasby, Dean of UCalga...lags behind other countries in the number of diagn...nly solution to long wait times. The study,s autho...he current system. We hope this research will help...
...ch 5, 2009) -- Two highly lethal viruses that have...loroquine, an established drug used to prevent and...tudy by researchers at Weill Cornell Medical Colle...e two henipaviruses that are the subject of the st...
Other Medicine News:Health News:Retinal Gene Is Linked to Childhood Blindness 2Health News:Bias Against Obesity Is Found Among Future Dietitians 2Health News:Bias Against Obesity Is Found Among Future Dietitians 3Health News:Phoenix Health Systems Launches Total Security Program for the Healthcare Industry 2Health News:Sysmex Corporation Announces Organizational Changes 2Health News:Lack of strategies to manage MRI wait lists a key reason for excessive wait times 2Health News:Drug blocks 2 of world's deadliest emerging viruses 2Health News:Drug blocks 2 of world's deadliest emerging viruses 3
(Date:11/20/2009)...CK, Mass. and LONDON, Nov. 20 /PRNewswire-FirstCal... today announced that it has received 510(k) clear...DA) and CE Mark approval to market its WallFlex...nt of malignant esophageal strictures (obstruction... non-resectable esophageal cancer. ,, (Photo: ...
(Date:11/20/2009)...IN LAKES, N.J., Nov. 20 ...today announced the completion of its acquisition ...mpany that develops and manufactures molecular dia...May 2009, BD and HandyLab announced an exclusive a...ular assays on the HandyLab Jaguar(TM) platform, t...
(Date:11/19/2009)...INGHAM, Ala., Nov. 19 Bi...y announced the pricing of a public offering of 5,...are, resulting in gross proceeds of $48.75 million... pursuant to an effective shelf registration state...ange Commission. BioCryst has also granted the un...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Experimental Urine Test Spots Appendicitis 49786 1Experimental Urine Test Spots Appendicitis 49786 2YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 1YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 2YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 3YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 4YM BIOSCIENCES REPORTS DAIICHI SANKYO ENROLLS FIRST PATIENTS IN PHASE II FIRST LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 12750 5Capital BlueCross Products Receive Excellent National Accreditation 49781 1Capital BlueCross Products Receive Excellent National Accreditation 49781 2
...t. 28 Premier Research Group Limited,the internat...ded the Good,Clinical Practice Journal (GCPj) Awar... its Global Phase 2 Chronic Myeloid Leukemia team.... recognizes, celebrates, and rewards,corporate and... "Clinical Research Team of the Year" award honors...
... Leads Investment in Lutonix to Fund Human Clinica...ay announced the,close of a $20 million Series B f...M.D. and Lixiao Wang PhD, Lutonix is a medical dev...ialization of drug coated balloon,angioplasty tech...y and,peripheral artery stenosis caused by atheros...
Other Medicine Technology:Premier Research Honored as 'Clinical Research Team of the Year' at 2008 GCPj Awards 2Lutonix Inc. Announces $20 Million Series B Financing 2Lutonix Inc. Announces $20 Million Series B Financing 3
Illiterate 20' Test Chart
PowerLab/8SP
Worth 4 Dot Test
Kindergarten 20' Test - BC1263
Medicine Products: